WO2019073127A3 - Composition contenant de l'huile du cannabis - Google Patents

Composition contenant de l'huile du cannabis Download PDF

Info

Publication number
WO2019073127A3
WO2019073127A3 PCT/FR2018/000233 FR2018000233W WO2019073127A3 WO 2019073127 A3 WO2019073127 A3 WO 2019073127A3 FR 2018000233 W FR2018000233 W FR 2018000233W WO 2019073127 A3 WO2019073127 A3 WO 2019073127A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition containing
cannabis oil
containing cannabis
composition
sugar
Prior art date
Application number
PCT/FR2018/000233
Other languages
English (en)
Other versions
WO2019073127A2 (fr
Inventor
Gérard N'GUYEN
Original Assignee
Nguyen Gerard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nguyen Gerard filed Critical Nguyen Gerard
Publication of WO2019073127A2 publication Critical patent/WO2019073127A2/fr
Publication of WO2019073127A3 publication Critical patent/WO2019073127A3/fr
Priority to CONC2020/0005768A priority Critical patent/CO2020005768A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Abstract

Composition de type confiserie ou de type composition pharmaceutique, comprenant au moins : - De l'huile essentielle de Cannabis - Un support comprenant du sucre. De telles compositions permettent d'améliorer le bien-être d'un individu qui les consomme, sans danger pour la santé.
PCT/FR2018/000233 2017-10-12 2018-10-08 Composition phytoconcentrée et ses utilisations WO2019073127A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CONC2020/0005768A CO2020005768A2 (es) 2017-10-12 2020-05-12 Composición fitoconcentrada y sus usos

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1759583 2017-10-12
FR1759583 2017-10-12

Publications (2)

Publication Number Publication Date
WO2019073127A2 WO2019073127A2 (fr) 2019-04-18
WO2019073127A3 true WO2019073127A3 (fr) 2019-08-22

Family

ID=65818034

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2018/000233 WO2019073127A2 (fr) 2017-10-12 2018-10-08 Composition phytoconcentrée et ses utilisations

Country Status (2)

Country Link
CO (1) CO2020005768A2 (fr)
WO (1) WO2019073127A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022543584A (ja) * 2019-07-29 2022-10-13 ブライトシード・インコーポレイテッド 消化器の健康を改善するための方法
EP4098254A1 (fr) * 2021-06-04 2022-12-07 Assistance Publique, Hopitaux De Paris Cannabidiol à utiliser dans le traitement de la douleur résultant d'une maladie liée à l'indoléamine 2,3-dioxygenase-1 (ido1)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002069993A1 (fr) * 2001-03-06 2002-09-12 Forschungsinstitut Hiscia Verein Für Krebsforschung Composition pharmaceutique a base d'extraits de cannabis
CN103082275A (zh) * 2011-10-28 2013-05-08 冯松平 一种女性专用饮料泡腾片

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2973706B1 (fr) 2011-04-06 2016-05-20 Guyen Gerard Duc N Composition phyto-concentree essentielle decontracturante antispasmodique et de confort musculaire
US9763991B2 (en) 2013-06-13 2017-09-19 Cannabis Science International Holding B.V. Composition for the treatment of neurobehavioral disorders

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002069993A1 (fr) * 2001-03-06 2002-09-12 Forschungsinstitut Hiscia Verein Für Krebsforschung Composition pharmaceutique a base d'extraits de cannabis
CN103082275A (zh) * 2011-10-28 2013-05-08 冯松平 一种女性专用饮料泡腾片

Also Published As

Publication number Publication date
WO2019073127A2 (fr) 2019-04-18
CO2020005768A2 (es) 2020-07-31

Similar Documents

Publication Publication Date Title
WO2017095944A8 (fr) Procédés et compositions se rapportant à des chondrisomes provenant de produits sanguins
PH12018502268A1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
WO2019186284A3 (fr) Palet de cannabis à dose définie
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
MX2018011991A (es) Composiciones para el cuidado bucal con una exhibicion de saborizante eficaz.
MX2016014509A (es) Formulacion de vitamina soluble en grasa.
MX2018015125A (es) Nuevos compuestos antibacterianos.
AU2018301662A1 (en) Purified 2,5-furandicarboxylic acid pathway products
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
MX2017007371A (es) Compuestos antibacterianos que tienen un amplio espectro de actividad.
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
WO2019073127A3 (fr) Composition contenant de l'huile du cannabis
WO2016080796A3 (fr) Composition pharmaceutique contenant un composé sesquiterpénique et utilisable en vue de la prévention ou du traitement de maladies à médiation par stat3, et son utilisation
PH12017500357A1 (en) Lactic acid bacteria-containing composition
EA201991659A1 (ru) Композиция от кашля
NZ756986A (en) Health food and cosmetics for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells and a method of manufacturing a sprout-forcing grape seed-derived ingredient for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells
EA033297B1 (ru) Терапевтические и питательные композиции для функциональных нарушений работы пищеварительной системы
WO2015044434A3 (fr) Fluoro-9-méthyl-β-carboline
WO2015147834A8 (fr) Produits combinés au verre bioactif et au collagène et trousses
MY186185A (en) Encapsulated fillings
WO2017015408A8 (fr) Compositions de parfum d'hygiène
WO2020086650A3 (fr) Nouveaux composés
WO2016080666A3 (fr) Composition permettant de prévenir ou de traiter les caries dentaires et une parodontopathie, contenant de l'extrait d'ambrosia trifida l. ou une fraction de celle-ci comme principe actif
UA87106U (ru) Состав мармелада с оздоровительными свойствами "смакота" (вкуснятина)

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18857445

Country of ref document: EP

Kind code of ref document: A2